175 related articles for article (PubMed ID: 2185150)
1. Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
Hypertension; 1990 May; 15(5):459-68. PubMed ID: 2185150
[TBL] [Abstract][Full Text] [Related]
2. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
[TBL] [Abstract][Full Text] [Related]
3. In vivo pharmacology of DuP 753.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
Am J Hypertens; 1991 Apr; 4(4 Pt 2):288S-298S. PubMed ID: 1854454
[TBL] [Abstract][Full Text] [Related]
4. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Feb; 252(2):719-25. PubMed ID: 2179531
[TBL] [Abstract][Full Text] [Related]
5. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM
J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
[TBL] [Abstract][Full Text] [Related]
6. Central DuP 753 does not lower blood pressure in spontaneously hypertensive rats.
DePasquale MJ; Fossa AA; Holt WF; Mangiapane ML
Hypertension; 1992 Jun; 19(6 Pt 2):668-71. PubMed ID: 1592465
[TBL] [Abstract][Full Text] [Related]
7. Nonpeptide angiotensin II receptor antagonists. Studies with DuP 753 and EXP3174 in dogs.
Wong PC; Hart SD; Duncia JV; Timmermans PB
Eur J Pharmacol; 1991 Sep; 202(3):323-30. PubMed ID: 1748155
[TBL] [Abstract][Full Text] [Related]
8. Prolonged angiotensin II antagonism in spontaneously hypertensive rats. Hemodynamic and biochemical consequences.
Bunkenburg B; Schnell C; Baum HP; Cumin F; Wood JM
Hypertension; 1991 Sep; 18(3):278-88. PubMed ID: 1889842
[TBL] [Abstract][Full Text] [Related]
9. Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension.
Cachofeiro V; Sakakibara T; Nasjletti A
Hypertension; 1992 Feb; 19(2):138-45. PubMed ID: 1737647
[TBL] [Abstract][Full Text] [Related]
10. Effects of DuP 753 on renal function of normotensive and spontaneously hypertensive rats.
Fenoy FJ; Milicic I; Smith RD; Wong PC; Timmermans PB; Roman R
Am J Hypertens; 1991 Apr; 4(4 Pt 2):321S-326S. PubMed ID: 1854459
[TBL] [Abstract][Full Text] [Related]
11. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive and hormonal activity of MK 954 in spontaneously hypertensive rats.
Mizuno K; Niimura S; Tani M; Haga H; Gomibuchi T; Sanada H; Fukuchi S
Eur J Pharmacol; 1992 May; 215(2-3):305-8. PubMed ID: 1396995
[TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin subtype 1 and subtype 2 receptor antagonists in normotensive versus hypertensive rats.
Tofovic SP; Pong AS; Jackson EK
Hypertension; 1991 Dec; 18(6):774-82. PubMed ID: 1743758
[TBL] [Abstract][Full Text] [Related]
14. Nonpeptide angiotensin II receptor antagonists. Studies with EXP9270 and DuP 753.
Wong PC; Price WA; Chiu AT; Carini DJ; Duncia JV; Johnson AL; Wexler RR; Timmermans PB
Hypertension; 1990 Jun; 15(6 Pt 2):823-34. PubMed ID: 2351436
[TBL] [Abstract][Full Text] [Related]
15. Depressor effect of blocking angiotensin subtype 1 receptors in anterior hypothalamus.
Yang RH; Jin H; Wyss JM; Oparil S
Hypertension; 1992 May; 19(5):475-81. PubMed ID: 1568766
[TBL] [Abstract][Full Text] [Related]
16. Blocking hypothalamic AT1 receptors lowers blood pressure in salt-sensitive rats.
Yang RH; Jin H; Chen SJ; Wyss JM; Oparil S
Hypertension; 1992 Dec; 20(6):755-62. PubMed ID: 1452291
[TBL] [Abstract][Full Text] [Related]
17. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Oct; 255(1):211-7. PubMed ID: 2213556
[TBL] [Abstract][Full Text] [Related]
18. Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.
Chiu AT; McCall DE; Price WA; Wong PC; Carini DJ; Duncia JV; Wexler RR; Yoo SE; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Feb; 252(2):711-8. PubMed ID: 2313596
[TBL] [Abstract][Full Text] [Related]
19. Proximal nephron and renal effects of DuP 753, a nonpeptide angiotensin II receptor antagonist.
Xie MH; Liu FY; Wong PC; Timmermans PB; Cogan MG
Kidney Int; 1990 Sep; 38(3):473-9. PubMed ID: 2232490
[TBL] [Abstract][Full Text] [Related]
20. In vivo pharmacologic profile of SK-1080, an orally active nonpeptide AT1-receptor antagonist.
Lee BH; Seo HW; Kwon KJ; Yoo SE; Shin HS
J Cardiovasc Pharmacol; 1999 Mar; 33(3):375-82. PubMed ID: 10069671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
